| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |